Consensus statements on the clinical uses of pregabalin for Hong Kong.

Abstract

To facilitate the understanding of pregabalin and optimize its clinical usage in Hong Kong, an expert panel (11 psychiatrists, one family physician and one anesthesiologist) experienced in treating anxiety and somatic symptoms was invited to establish a set of consensus statements based on several discussion areas. A non-systematic literature search for relevant articles was conducted. The panelists addressed the discussion areas by sharing their clinical experience and available literature in a couple of meetings. At the last meeting, consensus statements derived from the proceedings were discussed and finalized. A total of 11 statements were ultimately accepted by panel voting based on their practicability of recommendation in Hong Kong. These statements are aimed to act as a practical reference for local clinicians when they consider prescribing pregabalin in different clinical situations.

• Authors: Patrick Po-Keung Kwong, Eric Yan-Kwong Chan, Eric Yat-Wo Cheung, Samson Yat-Yuk Fong, Wai Nip, Henry Hon-Kee Cheung, Isaac Pui-Lam Yip, King-Yee Chong, Ronnie Sze-Yuan Pao, Ka-Lok Tam, Man-Ho Tang, Simon Kin-Cheong Chan, Ki-Yan Mak
• Journal: Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists (Asia Pac Psychiatry) Vol. 12 Issue 3 Pg. e12403 (Sep 2020) ISSN: 1758-5872 [Electronic] Australia
• PMID: 32830438 (Publication Type: Journal Article)
• Copyright: © 2020 John Wiley & Sons Australia, Ltd.

Chemical References

• Calcium Channel Blockers
• Pregabalin

Topics

• Calcium Channel Blockers (therapeutic use)
• Consensus
• Hong Kong
• Humans
• Neuropharmacology (standards)
• Practice Guidelines as Topic (standards)
• Pregabalin (therapeutic use)
• Psychiatry (standards)
• Psychopharmacology (standards)